| | | April 6, 2022 Welcome to the BRAND NEW Stock Dork Premarket Report, your go-to guide for the day's biggest trading news and hottest premarket stocks. Keep an eye out for our Premarket Reports moving forward and, as always, we invite you to reply to this email with your feedback, suggestions, or comments. It's Wednesday, April 6th. Let's get ready to trade! |
| Tech stocks reversed course on Tuesday and led the NASDAQ to a 2.4% loss, and the S&P 500 fell 1.3% on the session. The Dow slid 0.8%, and the small-cap Russell 2K declined 2.4%. Futures are in the red ahead of today's opening bell, with S&P 500 contracts showing a 0.8% decline. BioXcel Therapeutics [BTAI] - Last Close: $19.88 BioXcel is up big on news that regulators have approved a key drug candidate. The US Food & Drug Administration has approved BioXcel's Igalmi sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Regulators said the decision was based on two clinical trials that demonstrated Igalmi was able to manage five key elements associated with agitation better than placebo. BioXcel said its planning on launching the medication in the US in the second quarter. BTAI was briefly halted by the NASDAQ earlier in the premarket, but it has since resumed trading and shares are up 16.5% in ahead of the opening bell. Tufin Software Technologies [TUFN] - Last Close: $9.03 News of a buyout deal is lifting shares of Tufin Software Technologies. Turn/River Capital has agreed to acquire Tufin Software in an all-cash deal valued at about $570 million. Under the terms of the deal, Tufin shareholders will get $13 per share for their holdings, and Tufin will become a private company upon closing. Turin's board has unanimously approved the deal, which includes a 30-day "go-shop" clause that will allow it to solicit more favorable deals until May 5th. The buyout deal is expected to close in the second quarter, and Turn is set to release its Q1 results by May 13th. The buyout deal is pushing shares of TUFN to a 42.9% gain in the premarket. Dakota Gold Corp [DC] - Last Close: $6.90 Shares of Dakota Gold are soaring on an exchange upgrade. The gold company rallied in today's premarket after news broke on Tuesday that its stock was being uplisted to the New York Stock Exchange's American exchange. Widespread global conflict and a fracturing of the international monetary system resulting from Western sanctions has generated a buzz around gold lately, and the sentiment could be putting additional momentum behind the stock's push higher. DC is up 48.6% on news of the upgrade. Citius Pharmaceuticals [CTXR] - Last Close: $1.84 Citius Pharmaceuticals is up sharply after a promising clinical data release. The specialty pharma firm reported topline results from Phase 3 trials of its antitumor I/ONTAK treatment for recurrent cutaneous T-cell lymphoma this morning, and the drug proved to be safe and effective. Citius said it expects to file a biologics license application with the US Food & Drug Administration in the second half of the year, based on study data. The firm's CEO, Myron Holubiak, said the results bring the company one step closer to launching its first commercial product next year if it's approved by the FDA. CTXR is trading actively with an 18.5% gain. |
| Gainers Guardion Health [GHSI] >> +18.0% Tonix Pharma [TNXP] >> +5.8% Tilray Brands [TLRY] >> +3.4% Decliners Reneo Phamaceuitcals [RPHM] >> (14.9%) Oncorus [ONCR] >> (10.8%) Anghami De Inc [ANGH] >> (11.3%) Tilray Brands [TLRY]... AM The Greenbrier Companies [GBX] ... AM Schnitzer Steel Industries [SCHN] ... AM RPM International [RPM] ... AM Levi Strauss & Co. [LEVI] ... PM Sprinklr [CXM] ... PM Simulations Plus [SLP] ... PM |
| Fed Open Market's Committee Minutes from March ... 2p |
| Thanks for reading! Don't forget, I'm always eager to hear from you. Reply to this email with your questions, comments, or general feedback, and Ill get back to you as soon as I can. Wishing you big returns on your investments this week, as always! - Michael "The Dork" Taylor P.S. Want My Alerts Delivered To Your Cell Phone? Sign up for mobile alerts and get the latest updates delivered to your cell. Disclaimer © 2022 TheStockDork.com. All rights reserved. This message was sent by TheStockDork.com and may contain commercial elements such as advertising. Read full terms here. |
|
|
|
| | |
|
